We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

26 Sep 2023 - 28 Sep 2023
26 Sep 2023 - 28 Sep 2023

POC Diagnostic Platform Offers Handheld, Instrument-Free PCR Testing for STIs

By HospiMedica International staff writers
Posted on 31 Mar 2022
Print article
Image: Sexual Health Click Test (Photo courtesy of Visby Medical)
Image: Sexual Health Click Test (Photo courtesy of Visby Medical)

Sexually transmitted infections (STIs) can cause serious complications, and they require communication with patient partners who may or may not be symptomatic who also need to be treated. Knowledge is vital to the prevention and treatment of STIs. Now, the first instrument-free PCR test detects three of the most common and treatable STIs with results available within 30 minutes, during the patient visit.

Visby Medical’s (San Jose, CA, USA) fast, single-use polymerase chain reaction (PCR) diagnostic test is intended for the multiplexed detection of STIs caused by Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV), using a self-collected vaginal swab with about 97% or greater accuracy. With the capability to detect three of the most common and treatable STIs, Visby’s Sexual Health Click Test is uniquely positioned to address women’s health needs and promote positive health outcomes.

The test offers PCR technology in palm-sized dimensions and provides accurate results in less than 30 minutes, with no additional instruments required. Patients provide a vaginal swab self-collected in privacy, and then receive results and proper treatment during the same visit, eliminating typical wait time. Generally, clinicians have to wait 24 to 48 hours after specimen collection to receive results, which commonly leads to patients being lost to follow-up. With the Visby device, patients can be tested, counseled, and treated during a single visit, all patients will receive the treatment they need, and none will be lost to follow-up.

With its highly accurate results, the Sexual Health Click Test reduces unnecessary over- and under-treatment and accelerates time to receive treatment, therefore decreasing the possibility of transmission and complications due to lack of, or improper, treatment. Immediate results during the patient visit also offer the opportunity to educate patients about STI prevention and risk reduction. Visby has been granted a 510(k) clearance and CLIA Waiver by the US Food and Drug Administration (FDA) to market its Sexual Health Click Test. The FDA-granted CLIA Waiver allows any healthcare setting with a CLIA Certificate of Waiver to administer the test during the patient’s appointment, eliminating the need to send specimens to a laboratory, and greatly reducing the time between initial testing and treatment. Use of the device could significantly reduce growing STI rates, especially in communities with limited access to testing.

“Empowering clinicians with immediate access to a lab-grade PCR result will help guide not just the right treatment, but also the right patient discussion during that single patient visit. This can help save time, money, and reduce anxiety for the patient and clinician alike, enabling expedited partner treatment,” said Gary Schoolnik, MD, an infectious disease expert, Chief Medical Officer at Visby Medical, and Professor of Medicine at Stanford University

“Accurate results can ensure the clinician is able to make informed decisions that can shorten infection duration, prevent transmission, and may lower the risk of complications, all while improving the patient and clinician experience,” added Visby Medical Founder and CEO, Adam de la Zerda, PhD, who is also Associate Professor at Stanford University School of Medicine.

Related Links:
Visby Medical 

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Gold Supplier
Calibration Syringe
Calibration Syringes
New
Integrated Medication Cart
Avalo ACi
New
Digital Single Channel ECG
ECG-11DII

Print article
Radcal

Channels

Critical Care

view channel
Image: Flexible thin-film electrodes placed directly on brain tissue have shown promise for diagnosis and treatment of epilepsy (Photo courtesy of Tokyo Tech)

Thin-Film Neural Electrodes Placed Directly on Brain Tissue Can Diagnose and Treat Epilepsy

Analyzing brain activity is crucial for diagnosing conditions like epilepsy and other mental health disorders. Among various methods, electroencephalography (EEG) is considered the least intrusive, using... Read more

Surgical Techniques

view channel
Image: The Canady Robotic AI Surgical System (Photo courtesy of JCRI-ABTS)

AI Robotic System Selectively Kills Microscopic Tumor Cells without Damaging Surrounding Tissue

When treating cancer, surgeons usually aim to remove the tumor along with a surrounding "margin" of healthy tissue to make sure all cancer cells have been taken out. However, even with advancements in... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more

Business

view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.